Discovering drugs for the treatment of Ebola virus
USAMRIID Ft Detrick United States
Pagination or Media Count:
Drug development for Ebola virus EBOV has been in progress for several decades, primarily fueled by concerns about the potential use of the Category A agent as a potential bioweapon. However, the unprecedented magnitude and scale of the 2014-2016 outbreak in West Africa, combined with the potential spread to other corners of the world, led to a renewed focus on medical countermeasures for Ebola virus disease EVD.
- Medicine and Medical Research